Quick coding chart: Presumptive drug screens — 80305-80307

Why This Topic Matters

Presumptive drug screen billing can affect reimbursement, compliance review, and medical necessity documentation. This chart helps readers understand the scope of the topic and the related coding references before reviewing the full premium content.

Article Sections

1. Presumptive drug screen overview

   Introduces the topic of in-house presumptive drug screens and the general context for reviewing the chart. It also notes that the content is framed around current CPT reporting and Medicare oversight.

2. Code chart

   Presents the presumptive drug screen CPT code set and associated reporting framework. The section is organized as a quick comparison of the code entries covered in the chart.

3. Medicare payment indicators and RVUs

   Summarizes Medicare physician fee schedule information relevant to the chart. This section references payment-related indicators and annual fee schedule context.

4. Clinical lab fee schedule, 2019

   Provides laboratory fee schedule context for the codes included in the chart. The section is limited to the 2019 schedule information referenced in the article.

5. Medically unlikely edits, Jan. 1, 2019

   Lists utilization edit context tied to the chart and its effective date. The section addresses edit status and rationale at a summary level.

6. Sample ICD-10-CM codes that may support medical necessity

   Displays example diagnosis codes referenced as supporting documentation for presumptive drug screen medical necessity. The list is presented as sample reference material and is not all-inclusive.

7. Coder’s notes

   Contains brief editorial guidance about scrutiny and reporting considerations associated with the chart. It serves as a closing note for readers applying the reference material.